Auryxia Tablet, Film Coated
Product Images NDC 59922-631

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Auryxia (NDC 59922-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akebia Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ferric Citrate Structure (Keryx Figure 1)

Ferric Citrate Structure (Keryx Figure 1)
This text provides two equations with two unknown variables, x and y. The first equation states that x is equal to 0.70 minus 0.87, and the second equation states that y is equal to 19 minus 33. These equations could be solved using algebra to find numerical values for x and y.*
FDA Label Image

Figure 1: Serum Phosphorus Control Over 52 Weeks (Keryx Figure 2)

Figure 1: Serum Phosphorus Control Over 52 Weeks (Keryx Figure 2)
This seems to be a table or some sort of data analysis. It shows the mean serum phosphorus levels in mg/dL for different study time periods (active-controlled periods) for a substance called Ferric Gtrate. However, the formatting of the text is not very clear, making it difficult to interpret accurately.*
FDA Label Image

Bottle Label (Keryx Figure 3)

Bottle Label (Keryx Figure 3)
Each tablet of Auryxia contains 210 mg of ferric iron as ferric citrate. It is advised to see the package insert for dosage information before use. The tablet is stored at a temperature range of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit) with excursions up to 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit) and should be protected from moisture. The product should be kept away from the reach of children as accidental overdose of iron-containing products can be fatal for children under 6. In case of an accidental overdose, contact a doctor or a poison control center immediately. The product is manufactured for KERYX BIOPHARMACEUTICALS, INC., a wholly-owned subsidiary of Akebia Therapeutics, Inc., based in Cambridge, MA 02142. FD&C Yellow No. 6 is included in the product, and the National Drug Code for this product is 59922-631-01 for RX ONLY use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.